AGM Statement

RNS Number : 0712D
Inspiration Healthcare Group PLC
25 June 2021
 

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

 

 

AGM Statement

 

 

Inspiration Healthcare Group plc (AIM:IHC), the global medical technology company,  provides the following statement from  the Chairman, Mr Mark Abrahams , ahead of its Annual General Meeting (AGM), which is being held at 11.30 a.m. today:

 

"At the time of our Final results in April this year, I commented that our financial year had started well and was in line with our expectations with a strong order book across the Group, albeit that we recognised that there would be challenges as the world continued to deal with the impact from the Covid-19 pandemic. I can now confirm that the start to the financial year has been more than pleasing with interest in our products remaining high and that our order book remains strong.

 

Most recently we were very pleased to announce that Project Wave had recruited its first patient, remembering that this is the first time our Group has conducted a clinical trial of a product it has designed prior to CE marking. Also, we have announced that we received approvals for the SLE6000 ventilators in Japan and China and at the same time have reported on the positive progress being made on the integration with our new colleagues at SLE and the impact this is having on the wider Group. All of these give us confidence for this financial year and beyond.

 

The planned investment in the business is gaining momentum and it is exciting to see the concepts for the new factory layouts and offices taking shape where we will soon be able to showcase great British technology and where we can continue to work towards achieving our strategic goals with enthusiasm and developing the business further."

 

 

Enquiries:

 

Inspiration Healthcare Group plc

Neil Campbell, Chief Executive Officer

Jon Ballard, Chief Financial Officer

Tel: 01455 840555

 

Nominated Adviser & Broker

Cenkos Securities plc

Mark Connelly

Stephen Keys

Tel: 0207 397 8900

 

Cadogan PR 

Alex Walters

alex.walters@cadoganpr.com

Tel: 07771 713608

 

About Inspiration Healthcare Group

 

www.inspirationhealthcaregroup.plc.uk

 

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high-quality, innovative products to patients around the world which help to improve patient outcomes, and it actively invests in innovative product opportunities and disruptive technologies.

 

The Group currently consists of three companies: Inspiration Healthcare Ltd, SLE Ltd and Viomedex Ltd and under these brands the Group sells neonatal intensive care and operating theatre equipment around the work through a network of distributors into over 75 countries.  Products range from highly sophisticated capital equipment through to single use disposables all that can help improve outcomes of extremely sick patients.

 

In the UK and Ireland the Group offers direct sales for most of its products supported by Technical Service offering on site and return to base repair and maintenance along with 24/7 emergency hire of equipment and long term lease arrangements for its own brand products.  The Group also acts as a distributor for 3rd party companies that wish to access the NHS using the Group's sales and service expertise and knowledge of the NHS

 

The Group invests in growth through Research and Development holding numerous patents on its technology and has strong links with academic Key Opinion Leaders around the world and supports clinical research in the field of neonatal intensive care.

 

Further information on Inspiration Healthcare Group plc can be seen at  www.inspirationhealthcaregroup.plc.uk  

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMUSONRAOUNUAR
UK 100

Latest directors dealings